nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—corpus luteum—hypothyroidism	0.225	0.273	CbGeAlD
Nandrolone phenpropionate—CYP19A1—seminiferous tubule of testis—hypothyroidism	0.19	0.231	CbGeAlD
Nandrolone phenpropionate—AR—seminiferous tubule of testis—hypothyroidism	0.168	0.205	CbGeAlD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—SHBG—hypothyroidism	0.0188	0.14	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—THRA—hypothyroidism	0.0188	0.14	CbGpPWpGaD
Nandrolone phenpropionate—AR—adrenal cortex—hypothyroidism	0.0172	0.0209	CbGeAlD
Nandrolone phenpropionate—AR—heart—hypothyroidism	0.0167	0.0202	CbGeAlD
Nandrolone phenpropionate—CYP19A1—gonad—hypothyroidism	0.0161	0.0196	CbGeAlD
Nandrolone phenpropionate—AR—cardiovascular system—hypothyroidism	0.0157	0.0191	CbGeAlD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0149	0.11	CbGpPWpGaD
Nandrolone phenpropionate—Etonogestrel—SHBG—hypothyroidism	0.0144	0.341	CrCbGaD
Nandrolone phenpropionate—AR—gonad—hypothyroidism	0.0143	0.0173	CbGeAlD
Nandrolone phenpropionate—CYP19A1—adrenal gland—hypothyroidism	0.014	0.0171	CbGeAlD
Nandrolone phenpropionate—CYP19A1—blood—hypothyroidism	0.014	0.0171	CbGeAlD
Nandrolone phenpropionate—AR—pituitary gland—hypothyroidism	0.0139	0.0169	CbGeAlD
Nandrolone phenpropionate—CYP19A1—thyroid gland—hypothyroidism	0.0136	0.0165	CbGeAlD
Nandrolone phenpropionate—CYP19A1—female gonad—hypothyroidism	0.0131	0.0159	CbGeAlD
Nandrolone phenpropionate—AR—adrenal gland—hypothyroidism	0.0124	0.0151	CbGeAlD
Nandrolone phenpropionate—AR—blood—hypothyroidism	0.0124	0.0151	CbGeAlD
Nandrolone phenpropionate—AR—Nuclear Receptors—THRB—hypothyroidism	0.0121	0.0901	CbGpPWpGaD
Nandrolone phenpropionate—AR—thyroid gland—hypothyroidism	0.012	0.0146	CbGeAlD
Nandrolone phenpropionate—CYP19A1—testis—hypothyroidism	0.0116	0.0141	CbGeAlD
Nandrolone phenpropionate—AR—female gonad—hypothyroidism	0.0116	0.0141	CbGeAlD
Nandrolone phenpropionate—CYP19A1—liver—hypothyroidism	0.011	0.0133	CbGeAlD
Nandrolone phenpropionate—AR—testis—hypothyroidism	0.0103	0.0125	CbGeAlD
Nandrolone phenpropionate—Levonorgestrel—SHBG—hypothyroidism	0.0102	0.241	CrCbGaD
Nandrolone phenpropionate—AR—liver—hypothyroidism	0.00972	0.0118	CbGeAlD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00958	0.0712	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—SHBG—hypothyroidism	0.00826	0.196	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00732	0.0543	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—BGLAP—hypothyroidism	0.0062	0.046	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00608	0.0452	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—SHBG—hypothyroidism	0.00482	0.114	CrCbGaD
Nandrolone phenpropionate—Testosterone—SHBG—hypothyroidism	0.00455	0.108	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—POMC—hypothyroidism	0.00412	0.0306	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00399	0.0296	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00392	0.0291	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—VAV3—hypothyroidism	0.00343	0.0255	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00309	0.0229	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—THRA—hypothyroidism	0.00257	0.0191	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ZNF764—hypothyroidism	0.00192	0.0143	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00192	0.0142	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00183	0.0136	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—THRB—hypothyroidism	0.00166	0.0123	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00156	0.0116	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00155	0.0115	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—THRA—hypothyroidism	0.00124	0.00918	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—IYD—hypothyroidism	0.000973	0.00723	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NKX2-5—hypothyroidism	0.000881	0.00654	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000848	0.0063	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ATP5O—hypothyroidism	0.000827	0.00614	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—POMC—hypothyroidism	0.000825	0.00613	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—THRB—hypothyroidism	0.000797	0.00592	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TPO—hypothyroidism	0.000778	0.00578	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000721	0.00535	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TSHB—hypothyroidism	0.00036	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3C2A—hypothyroidism	0.000321	0.00238	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000317	0.00235	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A5—hypothyroidism	0.00027	0.002	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—POMC—hypothyroidism	0.000141	0.00105	CbGpPWpGaD
